Literature DB >> 6446277

Multiple sclerosis associated with eosinophilic vasculitis, pericarditis, and hypocomplementemia.

K Tanphaichitr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6446277     DOI： 10.1001/archneur.1980.00500540092017

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  6 in total

1.  Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Takahisa Masaki; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-01-02       Impact factor: 3.478

2.  Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors.

Authors:  B Cai; M J Spencer; G Nakamura; L Tseng-Ong; J G Tidball
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis.

Authors:  R P Gladue; L A Carroll; A J Milici; D N Scampoli; H A Stukenbrok; E R Pettipher; E D Salter; L Contillo; H J Showell
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

4.  An association between multiple sclerosis and type I diabetes mellitus.

Authors:  E Wertman; N Zilber; O Abramsky
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

5.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Raul N Mandler; Dorian McGavern; Wolfgang Bruck; Gerald Gleich; Richard M Ransohoff; Corinna Trebst; Brian Weinshenker; Dean Wingerchuk; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

6.  Cross-reactive myelin antibody induces renal pathology.

Authors:  Lisa K Peterson; Takahisa Masaki; Steven R Wheelwright; Ikuo Tsunoda; Robert S Fujinami
Journal:  Autoimmunity       Date:  2008-11       Impact factor: 2.815
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.